By engaging with the right medical experts as early as possible in a drug’s lifecycle, pharmaceutical companies can gain enduring competitive edge. However, despite medical affairs departments continually undergoing profound change and growth, studies show 50% of new drug launches fail to meet company expectations. Could embracing AI in life sciences help to tackle this trend?
Recent posts by David Bennett
2 min read
When we consider the role of artificial intelligence in life sciences, it already has a proven track record as an effective tool to support pharmaceutical research. However, companies are also moving fast to explore the transformational impact it can have on their commercial operations, such as sales and marketing.